Megha Salani, MD
Nephrology · Nashville, TNNPI 1598022493
Payments from drug & device makers
Across 22 payments — averaging $239.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk AS$2K
- Quanta Dialysis Technologies Inc$2K
- Vantive US Healthcare LLC$1K
- Outset Medical Inc$58
- Cormedix Inc.$39
- Baxter Healthcare$21
- plus $31 from 2 others
What the payments were for
- Speaking & faculty fees$2,00047%
- Travel & lodging$1,61838%
- Food & beverage$64615%
- Education$120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk AS | 5 | $2,038 |
| Quanta Dialysis Technologies Inc | 1 | $2,000 |
| Vantive US Healthcare LLC | 11 | $1,089 |
| Outset Medical Inc | 1 | $58 |
| Cormedix Inc. | 1 | $39 |
| Baxter Healthcare | 1 | $21 |
| Nxstage Medical, Inc. | 1 | $19 |
| Vifor Pharma, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SC+ Hemodialysis Machine$2,000
- Renal - Chronic$930
How this compares
$5,276 in reported general payments places this provider in the 70th percentile of 229 nephrology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 32 | $47,772 |
| LokelmaSodium Zirconium Cyclosilicate | 38 | $41,432 |
| VeltassaPatiromer Calcium Sorbitex | 28 | $38,907 |
| FarxigaDapagliflozin Propanediol | 24 | $26,722 |
| KerendiaFinerenone | 15 | $14,024 |
| Sevelamer Carbonate | 72 | $7,075 |
| Calcium Acetate | 69 | $4,401 |
| Nifedipine ErNifedipine | 74 | $1,923 |
| Bumetanide | 16 | $1,904 |
| Potassium Citrate ErPotassium Citrate | 15 | $1,111 |
| Calcitriol | 50 | $578 |
| Losartan Potassium | 57 | $476 |
| Furosemide | 73 | $466 |
| Torsemide | 17 | $353 |
| Amiloride Hcl | 25 | $348 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Nashville
- Anna BurgnerNashville$788K
- Peter ReeseNashville$613K
- Jamie DwyerNashville$493K
- Anthony LangoneNashville$377K
- Adriana HungNashville$270K
- Volker HaaseNashville$269K
- Edward GouldNashville$197K
- Natalie McCallNashville$111K
- Talat IkizlerNashville$96K
- James LutherNashville$93K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.